FINANCIALS

KROS Keros Therapeutics Inc 1664710

Income Statement
Revenue	kros-20241231	3,550,000
Net Income	kros-20241231	-187,353,000
Profit Margin		-5277.55%

Balance Sheet
Current Assets	588,893,000
Assets	615,886,000
Current Liabilities	27,450,000
Liabilities	44,333,000
Equity	571,553,000
Shares Out	37,522,000

Cash Flow Statement
Operating Cash Flow	-160,869,000
Investing Cash Flow	-1,931,000

Market Analysis
Market Cap	2,065,215,867
Price	11.34
BVPS	15.23
PB	0.75
EPS	-5.13
PS	145.44
FCF	-162,800,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view KROS documents filed with the SEC.

KROS Filings Clear

View A List of Tickers